CIK 0001372299 · Non-accelerated filer<br>Smaller reporting company
Ocugen, Inc.
Sign in to watch- Ticker
- OCGN
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 484-328-4701
- Business address
- 11 GREAT VALLEY PARKWAY, MALVERN, PA, 19355
- Former names
- HISTOGENICS CORP
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $1,088,801
- in 2 filings, $1.1M under 10b5-1 plans
Net −$1,088,801. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-03 | Upadhyay Arun Chief Scientific Officer | Shares withheld for taxes | −7,102 | $1.25 | $9K | 392,981 |
| 2023-01-03 | Crespo Jessica CAO/SVP, Finance | Shares withheld for taxes | −1,913 | $1.25 | $2K | 161,478 |
| 2023-01-03 | Musunuri Shankar Chief Executive Officer | Shares withheld for taxes | −37,877 | $1.25 | $47K | 2,190,073 |
| 2023-01-03 | Upadhyay Arun Chief Scientific Officer | Grant or award | +315,924 | 400,083 | ||
| 2023-01-03 | Upadhyay Arun Chief Scientific Officer | Grant or award · Option (Right to Buy) | +379,357 | 379,357 | ||
| 2023-01-03 | Crespo Jessica CAO/SVP, Finance | Grant or award | +122,951 | 163,391 | ||
| 2023-01-03 | Crespo Jessica CAO/SVP, Finance | Grant or award · Option (Right to Buy) | +147,638 | 147,638 | ||
| 2023-01-03 | Musunuri Shankar Chief Executive Officer | Grant or award | +1,475,410 | 2,227,950 | ||
| 2023-01-03 | Musunuri Shankar Chief Executive Officer | Grant or award · Option (Right to Buy) | +1,771,654 | 1,771,654 | ||
| 2022-12-16 | Musunuri Shankar Chief Executive Officer | Option exercise | +95,809 | $0.51 | $49K | 848,349 |
| 2022-12-16 | Musunuri Shankar Chief Executive Officer | Sale | −95,809 | $1.43 | $137K | 752,540 |
| 2022-12-16 | Musunuri Shankar Chief Executive Officer | Option exercise · Option (Right to Buy) | −95,809 | 426,543 | ||
| 2022-10-14 | Musunuri Shankar Chief Executive Officer | Option exercise | +100,000 | $0.51 | $51K | 852,540 |
| 2022-10-14 | Musunuri Shankar Chief Executive Officer | Sale | −100,000 | $1.66 | $166K | 752,540 |
| 2022-10-14 | Musunuri Shankar Chief Executive Officer | Option exercise · Option (Right to Buy) | −100,000 | 522,352 | ||
| 2022-10-06 | Kumar Ramesh Director | Option exercise | +4,500 | $0.51 | $2K | 4,500 |
| 2022-10-06 | Kumar Ramesh Director | Sale | −4,500 | $1.83 | $8K | 0 |
| 2022-10-06 | Kumar Ramesh Director | Option exercise · Option (Right to Buy) | −4,500 | 4,500 | ||
| 2022-08-11 | Castillo Kirsten Director | Option exercise | +42,000 | $0.28 | $12K | 92,000 |
| 2022-08-11 | Castillo Kirsten Director | Sale | −42,000 | $2.91 | $122K | 50,000 |
Page 4 of 27 · 525 trades